Magellan Health CEO and leadership

Mostafa Kamal is a Chief Executive Officer at MAGELLAN HEALTH INC and is based in New York, New York. He has worked as Strategy, Pricing & Analytics at EXPRESS SCRIPTS INC; SVP & General Manager, Magellan Rx Specialty & Chief Underwriting Officer at Magellan Rx Management; and Pricing Strategy at Cendant. Mostafa attended Rutgers University.

Dr. Carney is a board-certified internist and a board-certified psychiatrist and executive with strategic clinical leadership experience, serving as chief medical officer for Magellan Health and MagellanRx Management. In this key leadership role, Dr. Carney advances Magellan Health’s clinical mission and further position the company’s significant leadership capabilities in clinical engagement. She also serves as the chief medical officer of Magellan Rx Management, leading the development and implementation of innovative, integrated clinical programs for customers and members of Magellan’s pharmacy business segment. She previously served as the senior vice president and chief medical officer for Behavioral Health and Specialty Medicine of Magellan Healthcare. Dr. Carney also served as chief medical officer for Magellan Complete Care of Arizona.

Prior to Magellan, Dr. Carney’s distinguished clinical and professional experiences include serving in a variety of chief medical officer roles working with Medicare, Medicaid, commercial (private) and Marketplace populations and programs. Dr. Carney also served as the medical director for the state of Indiana Office of Medicaid Policy and Planning and helped launch the state’s early Medicaid expansion products and its mental health transformation initiatives.

Dr. Carney currently serves on the Opioid Technical Expert Panel (TEP) assembled by the NQF pursuant to the Substance Use Disorder Prevention that Promotes Opioid Record and Treatment for Patients and Communities Act (Pub. L. 115‐271), and the Mental Health and Substance Use Measure Development TEP under the American Psychiatric Association’s cooperative agreement with the Centers for Medicare & Medicaid Services. She also has served on a variety of national and state committees, including the NQF’s Measure Incubator for Appropriate Pain Management Strategy Expert Panel; NQF’s National Quality Partners™ Opioid Stewardship Action Team; NQF’s Behavioral Health Measures Committee; and, Governor’s Mental Health Commission. She also has had an extraordinary clinical research and teaching career with various academic appointments.

Derrick Duke is a Chief Risk Officer at MAGELLAN HEALTH INC, Board Member at MID-WEST NATIONAL LIFE INS CO., and Exec VP/COO/Chief Invsmt Ofcr at Healthmarkets Inc. He has worked as VP/Chief Investment Officer at Uici. Derrick works or has worked as Senior VP/CIO at MID-WEST NATIONAL LIFE INS CO.. He attended The University of Texas at Arlington - College of Business between 1991 and 1994, Hardin-Simmons University between 1984 and 1988, and University of Texas System.

Senior Vice President, Chief Transformation Officer at Magellan Health | Executive | Operations Leader | Strategy | Continuous Improvement | Growth Optimization

Experienced Partner with a demonstrated history of working in the hospital, healthcare and employee benefit industry. Skilled in Senior Management, Sales Management, Start-Ups and Turnarounds contributing to organic and inorganic profitable growth. Strong entrepreneurship professional with a BS focused in International and Business Management from St. John's University.

Senior Vice President, Chief Transformation Officer at Magellan Health | Executive | Operations Leader | Strategy | Continuous Improvement | Growth Optimization